Andrew Pierce

Dr. Andrew Pierce serves as an Honorary Lecturer (Teaching & Research) in the Division of Cancer Sciences within the Faculty of Biology, Medicine and Health at the University of Manchester. He is actively affiliated with the Manchester Cancer Research Centre, a partnership between the University, Cancer Research UK, and The Christie NHS Foundation Trust. His research profile demonstrates significant contributions to cancer proteomics and molecular oncology.

Dr. Pierce's research interests span multiple areas of cancer biology with particular expertise in proteomics applications for biomarker discovery. His work focuses on endometrial cancer diagnostics, myeloid malignancies, receptor tyrosine kinase signaling pathways, and stem cell biology. The fingerprint analysis of his research output shows strong concentrations in proteomics (100%), myeloid biology (97%), receptor tyrosine kinase research (88%), and additional significant work in stem cell biology (43%), oncogenes (43%), proteome analysis (35%), tyrosine kinase signaling (33%), and p53 research (32%).

Analysis of his recent publications reveals a clear trajectory in developing diagnostic and therapeutic approaches for cancer, particularly focusing on proteomic and metabolomic biomarker discovery for endometrial cancer and targeted therapies for JAK2-mutant conditions. His work bridges basic molecular research with clinical applications, often utilizing advanced mass spectrometry techniques and proteomic profiling.

Dr. Pierce has supervised 2 students according to institutional records and maintains active collaborations with researchers including Whetton, Crosbie, and Njoku. His research has garnered attention across social media platforms and academic networks, with several publications receiving significant readership on Mendeley and mentions in news outlets.